InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (12 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
12
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Farnum Rhonda, Directrice Exécutive et Responsable des Affaires Médicales. Officer active across 1 company, notably Theravance Biopharma, Inc.. Aggregated, 35 reports have been recorded. Breakdown: 0 buy · 12 sells. Total volume traded: €684k. History available since 14 December 2021. The latest transaction was filed on 20 August 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Farnum Rhonda
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations35 total
5,667 shares@ US$16.95Ordinary SharesSEC:0001898490-26-000012:0
18,750 shares0Ordinary SharesSEC:0001898490-26-000006:0
7,767 shares@ US$13.91635.3% of flowOrdinary SharesSEC:0001898490-26-000004:0
13,929 shares@ US$19.669.8% of flowOrdinary SharesSEC:0001898490-26-000002:0
7,767 shares@ US$18.74995.8% of flowOrdinary SharesSEC:0001898490-25-000008:0
9,060 shares@ US$17.907.0% of flowOrdinary SharesSEC:0001898490-25-000006:0
9,096 shares@ US$13.395.6% of flowOrdinary SharesSEC:0001415889-25-022794:0
682 shares@ US$11.39270.4% of flowOrdinary SharesSEC:0001415889-25-019869:0
24,000 shares@ US$11.0013.8% of flowOrdinary SharesSEC:0001415889-25-015642:0
9,120 shares@ US$9.455.3% of flowOrdinary SharesSEC:0001415889-25-014257:0
4,000 shares@ US$9.002.2% of flowOrdinary SharesSEC:0001415889-25-011227:0
75,000 shares0Ordinary SharesSEC:0001415889-25-006668:0
5,283 shares0Ordinary SharesSEC:0001415889-25-005347:0
4,000 shares@ US$9.002.4% of flowOrdinary SharesSEC:0001415889-25-001957:0
9,178 shares@ US$9.976.0% of flowOrdinary SharesSEC:0001415889-24-027564:0
4,000 shares@ US$9.002.3% of flowOrdinary SharesSEC:0001415889-24-026766:0
9,222 shares@ US$8.224.7% of flowOrdinary SharesSEC:0001415889-24-022084:0
4,000 shares@ US$9.002.3% of flowOrdinary SharesSEC:0001415889-24-019534:0
9,268 shares@ US$9.105.4% of flowOrdinary SharesSEC:0001415889-24-014133:0
37,500 shares0Ordinary SharesSEC:0001415889-24-010320:0
18,219 shares@ US$8.9210.5% of flowOrdinary SharesSEC:0001415889-24-004958:0
7,982 shares@ US$10.375.3% of flowOrdinary SharesSEC:0001415889-23-015446:0
1,807 shares@ US$9.471.1% of flowOrdinary SharesSEC:0001415889-23-012621:0
10,460 shares@ US$9.706.5% of flowOrdinary SharesSEC:0001415889-23-012510:0
1,790 shares@ US$11.131.3% of flowOrdinary SharesSEC:0001415889-23-009636:0
25 of 35 declarations
About Farnum Rhonda
Farnum Rhonda is Directrice Exécutive et Responsable des Affaires Médicales at Theravance Biopharma, Inc., where her listed function is SVP, COMM & MEDICAL AFFAIRS. She has 34 filings in total, and across the recent filings we hold, buys are 0 EUR and sells are 683914 EUR, with filings dated from 2021-12-16 to 2026-04-03; the most common transaction nature is Retenue fiscale.
